Company Filing History:
Years Active: 2000
Title: James Elton Gilchrist: Innovator in Rotavirus Research
Introduction
James Elton Gilchrist is a notable inventor based in Saskatoon, Canada. He has made significant contributions to the field of medical research, particularly in the area of rotavirus infections. His work focuses on developing peptide compositions that can aid in the diagnosis, therapy, and prevention of these infections.
Latest Patents
James Elton Gilchrist holds a patent for "Rotavirus peptide compositions and methods of use." This patent highlights the utility of various subunits of rotaviral proteins in combating rotaviral infections. Specifically, the subunits represented by positions 40-60 of VP6, 232-255 and 240-248 of VP4, and 247-259 and 275-295 of VP7 have been identified as particularly useful. Furthermore, the VP4 subunits possess therapeutic value by competing with the native viral protein during a critical step in the infection process. He has 1 patent to his name.
Career Highlights
James Elton Gilchrist is affiliated with the University of Saskatchewan, where he conducts his research. His work has been instrumental in advancing the understanding of rotavirus and its implications for public health.
Collaborations
He has collaborated with notable colleagues, including Marta Iris Sabara and Patrick John Frenchick, to further enhance the impact of his research.
Conclusion
James Elton Gilchrist's innovative work in rotavirus research exemplifies the importance of scientific inquiry in addressing public health challenges. His contributions continue to pave the way for advancements in diagnosis and treatment options for rotaviral infections.